To procure the services of barc to assay serum biomarkers.

Ended Purchase Order Awarded Last action

Contract number
75N92018P00166
Awardee
Awarding agency
Obligated
$112,198

Award facts

Opportunity
Contract value 100% obligated
$112,198.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$2,468
Original award $114,666

About this award

The National Heart Lung and Blood Institute awarded a purchase order to Cerba Research USA, Inc. valued at $112,198 on July 31, 2018, to procure serum biomarker assay services. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of July 30, 2019. No small business set-aside applied to this procurement.

Quick answers

Who was awarded contract 75N92018P00166?

75N92018P00166 was awarded to Cerba Research Usa, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 31, 2018.

How much is contract 75N92018P00166 worth?

The government has obligated $112,198 on 75N92018P00166.

Was contract 75N92018P00166 competed?

The extent of competition for 75N92018P00166 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award